Company / Current Assets
TENAX THERAPEUTICS, INC. Current Assets History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$104.2M
FY2025
5-year range
$13.6M / $104.2M
FY2021-FY2025
Trend
+7.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $14M to $104M over the past 9 years.
Based on SEC 10-K filings.
$104M in FY2025 with a 10-year CAGR of +5.9%.
Improved from $14M to $104M over the past 9 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +5.9%
Key checks
Key Insights
- In FY2025, current assets increased 7.8% year-over-year.
- Lowest current assets in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $104.2M | +7.8% |
| FY2024 | $96.7M | +609.5% |
| FY2016 | $13.6M | -76.9% |
| FY2015 | $59.0M | +0.0% |
| FY2014 | $59.0M | +3100.8% |
| FY2013 | $1.8M | -30.0% |
| FY2012 | $2.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026